Back to Search Start Over

225P Nivolumab for cancer of unknown primary (CUP): Clinical efficacy and biomarker analysis from NivoCUP2 expanded access program (WJOG14620M).

Authors :
Tanizaki, J.
Yonemori, K.
Takiguchi, Y.
Akiyoshi, K.
Komine, K.
Onozawa, Y.
Sato, M.
Hirata, K.
Onoe, T.
Ishiguro, T.
Ito, A.
Chiba, Y.
Watanabe, H.
Togashi, Y.
Sakai, K.
Nishio, K.
Nakagawa, K.
Hayashi, H.
Source :
Annals of Oncology. 2024 Supplement 2, Vol. 35, pS305-S306. 2p.
Publication Year :
2024

Subjects

Subjects :
*CANCER of unknown primary origin
*NIVOLUMAB
*BIOMARKERS

Details

Language :
English
ISSN :
09237534
Volume :
35
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
179693557
Full Text :
https://doi.org/10.1016/j.annonc.2024.08.2229
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details